Insider filing · REGN
Huda Y Zoghbi
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Huda Y Zoghbi sold $7.2M of Regeneron Pharmaceuticals (REGN)
Executed Nov 3, disclosed Nov 5, 2 days later.
Value, as filed
$7.2M
7,439 sh across 2 lots
Executed
Nov 3
the trade date, as filed
Disclosed
Nov 5
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HZHuda Y Zoghbi (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $7.2M of REGN (7,439 sh across 2 lots, as filed), executed Nov 3.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Huda Y Zoghbi in REGN
REGNSALE
Regeneron Pharmaceuticals, Inc.
$640K800 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:14 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. $1.1M
1,426 sh across 6 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET